IntegraDose Compounding Services LLC has recalled 3,203 units of ceFAZolin injections, including 20 mL syringes and 115 mL bags, because they may not be sterile. The recall was initiated after a potential lack of sterility assurance was discovered. No injuries or illnesses have been reported to date, but these products were distributed to hospitals, pharmacies, and healthcare providers in New Hampshire, Massachusetts, and Minnesota.
Using a medication that is not sterile can result in serious or life-threatening infections. Because these medications are injected directly into the body, any bacterial or fungal contamination poses a significant health risk to patients.
Manufactured at 719 Kasota Ave SE, Minneapolis, MN.
Sterile Product manufactured at 719 Kasota Ave SE, Minneapolis, MN.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.